Pacific Biosciences
PACB
#6557
Rank
$0.72 B
Marketcap
$2.39
Share price
-5.16%
Change (1 day)
17.73%
Change (1 year)

Revenue for Pacific Biosciences (PACB)

Revenue in 2025 (TTM): $0.15 Billion USD

According to Pacific Biosciences 's latest financial reports the company's current revenue (TTM ) is $0.15 Billion USD. In 2024 the company made a revenue of $0.15 Billion USD a decrease over the revenue in the year 2023 that were of $0.20 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacific Biosciences from 2010 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $0.15 B0.37%
2024 $0.15 B-23.19%
2023 $0.20 B56.29%
2022 $0.12 B-1.69%
2021 $0.13 B65.43%
2020 $78.89 M-13.2%
2019 $90.89 M15.6%
2018 $78.62 M-15.88%
2017 $93.46 M3.04%
2016 $90.71 M-2.23%
2015 $92.78 M53.12%
2014 $60.59 M115.02%
2013 $28.18 M8.46%
2012 $25.98 M-23.27%
2011 $33.86 M1922.88%
2010 $1.67 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Illumina
ILMN
$4.28 B 2,673.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
$0.16 B 5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$43.94 B 28,329.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$43.73 B 28,192.06%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
$3.35 B 2,071.93%๐Ÿ‡บ๐Ÿ‡ธ USA